Cardiogen vs Pinealon
Moderate Research vs Well Studied
compatible Part of Khavinson bioregulator family; targets different tissue.
Molecular Data
Cardiogen Pinealon
Weight 460 Da 418.4 Da
Half-life Minutes (short peptide); effects persist via epigenetic changes Not established
Chain 4 amino acids 3 amino acids
Type Tetrapeptide bioregulator Tripeptide
Key Benefits
Cardiogen
01 Supports cardiac tissue repair and regeneration
02 Regulates cardiovascular gene expression
03 Improves myocardial function
04 May support post-cardiac event recovery
05 Epigenetic mechanism for targeted action
06 Works at DNA/nuclear level
07 Part of comprehensive anti-aging protocols
08 Well-researched Khavinson peptide
Pinealon
01 Direct DNA interaction
02 Neuroprotection
03 Cognitive enhancement
04 Excellent safety profile
05 40+ years of clinical use in Russia
Dosing Protocols
Cardiogen
10-20 mg daily / Once daily for 10-20 consecutive days
Research protocol 10 mg Daily for 10 days
Pinealon
Injectable: 5mg daily or 100-300mcg daily; Oral: 0.2mg twice daily / Injectable: daily for 20 days; Oral: morning and afternoon on empty stomach
Neuroprotection 5mg daily Once daily
Cognitive Enhancement 100-300mcg Daily or every other day
Anti-aging 5mg 20 days, 2-3x yearly
Side Effects
Cardiogen
Generally well-tolerated
Minimal side effects reported
Pinealon
Minimal injection site reactions
Mild gastrointestinal adjustment
Occasional headache
Fatigue
Contraindications
Active cardiac emergencies (seek medical care)
Known hypersensitivity
Pregnancy or breastfeeding
Pregnancy
Lactation
Research Evidence
Cardiogen Pinealon
Status Moderate Research Well Studied
References 3 studies 4 studies
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.